Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation

• C Green,
• J Dinnes,
• A Takeda,
• J Shepherd,
• D Hartwell,
• C Cave,
• E Payne,
• B Cuthbertson

Affiliations

C Green

Southampton Health Technology Assessments Centre (SHTAC), University of Southampton, UK

J Dinnes

A Takeda

J Shepherd

D Hartwell

C Cave

E Payne

B Cuthbertson